PROM1 and colorectal carcinoma: Other studies have also indicated that CD133 might not be a good CSC marker in CRC, since knocking-down the gene expression of CD133 does not induce cellular differentiation in CRC [42], and both CD133 positive and CD133 negative CRC subpopulations are capable of tumor initiation [43].